Search

everythinglearnresearchcommunity

for

Search:↓

Choosing the right patients, using proper techniques, and having thorough knowledge are key to preventing and managing dermal filler complications.

Men, especially older ones with health issues like prostate cancer, may have worse COVID-19 outcomes and could benefit from therapies targeting male hormones.

Some people who recover from COVID-19 continue to have symptoms like fatigue and cough for over 120 days, and some experience hair loss about 59 days after getting sick.

The document concludes that rapid identification, isolation, and strict infection control are crucial to manage SARS outbreaks.

Low-dose finasteride may cause lasting sexual dysfunction and suicidal thoughts in young men.

Spironolactone is an effective and well-tolerated first-line treatment for hidradenitis suppurativa in women.

Using finasteride or dutasteride may cause long-lasting erectile dysfunction.

A new skin-whitening agent using a peptide from wheat is safe and effective at reducing skin pigmentation.

The U.S. military's teledermatology program was effective in providing fast and successful skin care in remote locations, preventing unnecessary evacuations.

Male cancer patients have a higher risk of severe illness and death from COVID-19 than female patients.

Patients with chronic skin conditions on systemic treatments did not have worse COVID-19 outcomes and could resume their treatments after recovery.

Nanomaterials in biomedicine can improve treatments but may have risks like toxicity, needing more safety research.

COVID-19 can cause various skin issues, including rashes and hair loss, which usually heal on their own and don't always indicate severe illness.

ART for HIV/AIDS can cause side effects but is crucial for managing the infection.

The new FDA labeling rules provide more detailed drug safety information for pregnant and breastfeeding women, but more data is needed on the risks of many dermatologic drugs.

Indian dermatosurgical practitioners were given guidelines in 2011 to reduce infection risks, including hand hygiene, sterilization methods, operation theater standards, and proper waste disposal.

FPHL is common in women, influenced by genetics and hormones, and can be treated with medications, laser therapy, or hair transplantation.

Dermabrasion is a safe, effective way to improve skin appearance with minimal recovery time.

Alopecia areata leads to significantly higher healthcare costs due to more doctor visits and prescriptions.

Some synthetic carbohydrate receptors, especially compounds 3 and 15, show strong potential for treating Zika virus.

Certain liver diseases respond well to specific treatments and have varying risks for liver cancer.

The review found that COVID-19 can cause skin problems, including rashes and issues from wearing PPE, and suggests more research and protective measures for healthcare workers.

Timolol eye-drops can cause hair loss.

Some COVID-19 patients have different skin problems, which might be the only sign of the virus or related to other health issues.

Some alopecia treatments might help treat COVID-19, but more research is needed.

Hair loss can be caused by stress, infections, drugs, and various diseases, with treatment depending on accurate diagnosis.

Mesenchymal stem cells show promise in treating COVID-19 by reducing inflammation and aiding recovery, but more research is needed.

Using existing drugs for new treatments is cost-effective and safer.

MSC-Exos can aid organ development and offer therapeutic benefits for various conditions.

CDK4/6 inhibitors have improved treatment outcomes for certain advanced breast cancer patients.